carbostyril has been researched along with Gastroesophageal Reflux in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (71.43) | 24.3611 |
| 2020's | 2 (28.57) | 2.80 |
| Authors | Studies |
|---|---|
| Jang, E; Jeong, JE; Kim, MG; Lee, JY; Park, M | 1 |
| Gonik, MI; Ivashkin, VT; Trukhmanov, AS | 1 |
| Houwen, RHJ; Slae, M; van der Woerd, WL; Wilschanski, M | 1 |
| Choi, YK; Chung, JW; Gweon, TG; Kim, BW; Kim, CW; Kim, HG; Kim, JS; Park, JH; Park, SM | 1 |
| Anderson, A; Bourke, SJ; Brodlie, M; Dettmar, PW; Doe, S; Faruqi, S; Jones, R; Krishnan, A; McDonnell, M; Morice, AH; Pearson, JP; Ward, C; Zeybel, GL; Zeybel, M | 1 |
| Ichikawa, H; Kamada, K; Suzuki, T; Takagi, T; Tomatsuri, N; Yoshida, N; Yoshikawa, T | 1 |
| Adachi, K; Furuta, K; Furuta, T; Iwakiri, K; Kinoshita, Y; Koike, T; Komazawa, Y; Miki, M; Miwa, H; Oshima, T; Shimatani, T | 1 |
1 review(s) available for carbostyril and Gastroesophageal Reflux
| Article | Year |
|---|---|
Effects of new and emerging therapies on gastrointestinal outcomes in cystic fibrosis.
Topics: Aminophenols; Aminopyridines; Benzodioxoles; Body Mass Index; Chloride Channel Agonists; Cystic Fibrosis; Digestive System; Drug Combinations; Gastroesophageal Reflux; Humans; Hydrogen-Ion Concentration; Intestinal Diseases; Liver Diseases; Probiotics; Quinolones; Treatment Outcome; Weight Gain | 2017 |
2 trial(s) available for carbostyril and Gastroesophageal Reflux
| Article | Year |
|---|---|
Management of recurrence of symptoms of gastroesophageal reflux disease: synergistic effect of rebamipide with 15 mg lansoprazole.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Alanine; Anti-Ulcer Agents; Drug Synergism; Drug Therapy, Combination; Female; Gastroesophageal Reflux; Humans; Lansoprazole; Male; Middle Aged; Quinolones; Secondary Prevention | 2010 |
A study on the efficacy of rebamipide for patients with proton pump inhibitor-refractory non-erosive reflux disease.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Alanine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance; Esophageal pH Monitoring; Esophagoscopy; Female; Follow-Up Studies; Gastroesophageal Reflux; Humans; Lansoprazole; Male; Middle Aged; Prospective Studies; Proton Pump Inhibitors; Quinolones; Recurrence; Reference Values; Risk Assessment; Severity of Illness Index; Statistics, Nonparametric; Treatment Outcome; Young Adult | 2012 |
4 other study(ies) available for carbostyril and Gastroesophageal Reflux
| Article | Year |
|---|---|
Frequently reported adverse events of rebamipide compared to other drugs for peptic ulcer and gastroesophageal reflux disease.
Topics: Adverse Drug Reaction Reporting Systems; Aged; Alanine; Gastroesophageal Reflux; Humans; Peptic Ulcer; Quinolones; Xerostomia | 2022 |
[Rebamipide using in gastroesophageal reflux disease treatment].
Topics: Alanine; Anti-Ulcer Agents; Gastroesophageal Reflux; Humans; Proton Pump Inhibitors; Quinolones; Vascular Endothelial Growth Factor A | 2020 |
Additive Effects of Rebamipide Plus Proton Pump Inhibitors on the Expression of Tight Junction Proteins in a Rat Model of Gastro-Esophageal Reflux Disease.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Alanine; Animals; Anti-Ulcer Agents; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Esophageal Mucosa; Gastroesophageal Reflux; Male; Pantoprazole; Proton Pump Inhibitors; Quinolones; Rats; Rats, Sprague-Dawley; Tight Junction Proteins | 2018 |
Ivacaftor and symptoms of extra-oesophageal reflux in patients with cystic fibrosis and G551D mutation.
Topics: Adult; Aminophenols; Chloride Channel Agonists; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Drug Monitoring; Female; Gastroesophageal Reflux; Humans; Lung; Male; Mutation; Quinolones; Respiratory Aspiration; Respiratory Function Tests; Treatment Outcome; United Kingdom | 2017 |